| Date Filed | Type | Description |
| 09/11/2019 |
3
| Prioletti Mark Joseph SE (Director) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 05/14/2019 |
3
| Salvo Lawrence Anthony Sr (Director) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 12/14/2018 |
4
| Haines Harold Gray (Consultant) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Bought 555 shares
@ $2.1, valued at
$1.2k
Bought 945 shares
@ $2.12, valued at
$2k
|
|
| 12/14/2018 |
4
| Haines Harold Gray (Consultant) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Bought 300 shares
@ $1.03, valued at
$309
Bought 8,000 shares
@ $1.05, valued at
$8.4k
|
|
| 10/15/2018 |
4
| Ro Andrew (SVP & Chief Investment Officer) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 4,500 options to buy
@ $2.23, valued at
$10k
|
|
| 10/15/2018 |
4
| Purcell Richard David Jr. (SVP of Research & Drug Develop) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 4,500 options to buy
@ $2.23, valued at
$10k
|
|
| 10/15/2018 |
4
| MCGEE BRIAN (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,000 options to buy
@ $2.23, valued at
$2.2k
|
|
| 10/15/2018 |
4
| Lyman Gary Herbert (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,000 options to buy
@ $2.23, valued at
$2.2k
|
|
| 10/15/2018 |
4
| FLETCHER MARK (EVP General Counsel &Secretary) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 4,500 options to buy
@ $2.23, valued at
$10k
|
|
| 10/15/2018 |
4
| Corrao Mark (CFO & Treasurer) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 4,500 options to buy
@ $2.23, valued at
$10k
|
|
| 10/15/2018 |
4
| Centofanti Kevin (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,000 options to buy
@ $2.23, valued at
$2.2k
|
|
| 10/15/2018 |
4
| Anderson James H Jr. (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,000 options to buy
@ $2.23, valued at
$2.2k
|
|
| 10/15/2018 |
3
| Ro Andrew (Chief Investment Officer & SVP) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 10/15/2018 |
3
| Purcell Richard David Jr. (SVP Product Launch & Develop) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 10/15/2018 |
3
| Lyman Gary Herbert (Director) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 10/15/2018 |
3
| Corrao Mark (CFO & Treasurer) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 10/15/2018 |
3
| Centofanti Kevin (Director) has filed a Form 3 on GENEREX BIOTECHNOLOGY CORP |
| 02/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2016 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 02/12/2016 |
4
| FELLOWS STEPHEN (CFO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 02/12/2016 |
4
| Von Hofe Eric (President of Subsidiary) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 02/12/2016 |
4
| Brusegard David (COO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 02/12/2016 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 04/27/2015 |
4
| BARRATT JOHN P (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 10/08/2014 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 10/08/2014 |
4
| BARRATT JOHN P (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 10/08/2014 |
4
| MCGEE BRIAN (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 11/01/2013 |
4
| Von Hofe Eric (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
| 11/01/2013 |
4
| MCGEE BRIAN (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 890,804 options to buy
@ $0.001, valued at
$890.8 |
|
| 11/01/2013 |
4
| FLETCHER MARK (President and CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 2,254,640 options to buy
@ $0.001, valued at
$2.3k
|
|
| 11/01/2013 |
4
| FELLOWS STEPHEN (CFO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 845,492 options to buy
@ $0.001, valued at
$845.5 |
|
| 11/01/2013 |
4
| Brusegard David (COO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 845,492 options to buy
@ $0.001, valued at
$845.5 |
|
| 11/01/2013 |
4
| BARRATT JOHN P (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,810,345 options to buy
@ $0.001, valued at
$1.8k
|
|
| 11/01/2013 |
4
| Anderson James H Jr. (Director) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 718,391 options to buy
@ $0.001, valued at
$718.4 |
|
|